Comparison of chronic toxicity and carci
β
Nigel J. Walker; Michael E. Wyde; Lawrence J. Fischer; Abraham Nyska; John R. Bu
π
Article
π
2006
π
John Wiley and Sons
π
English
β 544 KB
## Abstract The cancer bioassay for 2,3,7,8βtetrachlorodibenzoβ__p__βdioxin (TCDD) conducted by the Dow Chemical company in the mid 70s has been used extensively for conducting quantitative cancer risk assessments for human exposure to TCDD. More recently the National Toxicology Program (NTP) condu